Suma Krishnan - President, R&D, Director, 10%+ Owner at Krystal Biotech, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, R&D, Director, 10%+ Owner
Issuer Symbol
KRYS on Nasdaq
All Insider Reports
All Insider Reports

Suma Krishnan - trading volume in the past year for Krystal Biotech, Inc.

Holdings reported by Suma Krishnan for Krystal Biotech, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,403,155 $373,831,922 $266.42 04 Mar 2026 Direct
Common Stock 90,000 $24,538,500 $272.65 04 Mar 2026 By SMK Trust
Common Stock 50,000 $13,632,500 $272.65 04 Mar 2026 By Krishnan Family Trust
Performance Stock Units 43,536 $3,968,775 $176.39 27 Feb 2026 Direct Common Stock
Restricted Stock Units 7,256 $2,822,240 $176.39 27 Feb 2026 Direct Common Stock
Stock Option (Right to Buy) 18,100 27 Feb 2026 Direct Common Stock

Transactions reported by Suma Krishnan for Krystal Biotech, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.